National Research (NASDAQ:NRC) Shares Gap Down to $46.15

National Research Co. (NASDAQ:NRC) gapped down before the market opened on Friday . The stock had previously closed at $46.15, but opened at $45.22. National Research shares last traded at $44.72, with a volume of 14,363 shares traded.

National Research Stock Down 2.4 %

The company has a 50 day simple moving average of $43.15 and a two-hundred day simple moving average of $43.71. The company has a quick ratio of 1.21, a current ratio of 1.21 and a debt-to-equity ratio of 0.20. The company has a market capitalization of $1.11 billion, a P/E ratio of 39.44 and a beta of 0.48.

National Research (NASDAQ:NRC) last issued its quarterly earnings data on Tuesday, August 1st. The company reported $0.29 earnings per share for the quarter. National Research had a return on equity of 39.94% and a net margin of 19.65%. The company had revenue of $36.16 million for the quarter.

National Research Announces Dividend

The firm also recently announced a None dividend, which will be paid on Friday, September 22nd. Stockholders of record on Monday, September 18th will be paid a dividend of $1.00 per share. The ex-dividend date of this dividend is Friday, September 15th. National Research’s dividend payout ratio is 41.03%.

Insider Activity

In other news, major shareholder Amandla Mk Trust sold 1,891 shares of the company’s stock in a transaction that occurred on Friday, June 23rd. The stock was sold at an average price of $45.04, for a total transaction of $85,170.64. Following the transaction, the insider now owns 4,246,320 shares of the company’s stock, valued at $191,254,252.80. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Over the last 90 days, insiders have sold 21,037 shares of company stock valued at $946,968. 2.00% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. BlackRock Inc. lifted its holdings in National Research by 6.3% during the second quarter. BlackRock Inc. now owns 1,077,811 shares of the company’s stock worth $46,896,000 after buying an additional 63,465 shares during the period. Morgan Stanley lifted its holdings in shares of National Research by 4,323.8% during the 4th quarter. Morgan Stanley now owns 974,253 shares of the company’s stock valued at $36,340,000 after purchasing an additional 952,230 shares during the last quarter. Vanguard Group Inc. lifted its holdings in shares of National Research by 0.8% during the 3rd quarter. Vanguard Group Inc. now owns 851,253 shares of the company’s stock valued at $33,879,000 after purchasing an additional 6,494 shares during the last quarter. Conestoga Capital Advisors LLC lifted its holdings in shares of National Research by 0.8% during the 1st quarter. Conestoga Capital Advisors LLC now owns 733,843 shares of the company’s stock valued at $31,929,000 after purchasing an additional 6,097 shares during the last quarter. Finally, Renaissance Technologies LLC lifted its holdings in shares of National Research by 0.7% during the 2nd quarter. Renaissance Technologies LLC now owns 369,584 shares of the company’s stock valued at $16,081,000 after purchasing an additional 2,600 shares during the last quarter. Institutional investors own 47.26% of the company’s stock.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty.